Furthermore, to evaluate the prognostic value of ATAD3A in bladder cancer, we performed a Kaplan–Meier analysis of data from public sources and found that the mean survival time of patients with high ATAD3A expression was significantly shorter than that of patients with low ATAD3A expression. The gene discussed is ATAD3A; the disease is urinary bladder carcinoma.